Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-01-30

Clinical Trial Update: Drug Use Survey of RESPIMAT in Patients With COPD

View source ↗

Summary

A completed clinical trial reports results from a drug-use survey of the RESPIMAT inhaler in patients with chronic obstructive pulmonary disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Spiriva (tiotropium)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Pulmonary Disease, Chronic Obstructive | Status: COMPLETED | Results posted: 2013-01-30